4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001312326-18-000002
Options or other derivatives
- Director bought 50,000 shares
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Nicholas W Director | 2018-05-31 | Purchase · Options | +50,000 | 160,000 | D: show line 1 in the form |
Loading xslF345X03/primary_doc.xml…